Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
N

NEO

Nasdaq

NEOGENOMICS INC

Latest disclosureOctober 5, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 3 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 64

Limited filing history
All64Buying0Selling3Other61
Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

3 of 64 trades · April 1, 2026 – October 1, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.
Sale disclosed

Greg D. Aunan

Chief Accounting Officer

Common Stock

Reported value
$321.4K
Reported price
$16.07 / share
Traded August 4, 2026Filed August 6, 2026SEC filing
Sale disclosed

Lynn A. Tetrault

Director

Common Stock

Reported value
$58.91K
Reported price
$11.10 / share
Traded June 15, 2026Filed June 17, 2026SEC filing
Sale disclosed

Lynn A. Tetrault

Director

Common Stock

Reported value
$59.92K
Reported price
$11.29 / share
Traded June 9, 2026Filed June 11, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
Chief Accounting OfficerCommon StockSale20,000$16.07 / share$321.4KAug 4Filed Aug 6 · 2d laterSEC filing
DirectorCommon StockSale10b5-15,307$11.10 / share$58.91KJun 15Filed Jun 17 · 2d laterSEC filing
DirectorCommon StockSale10b5-15,307$11.29 / share$59.92KJun 9Filed Jun 11 · 2d laterSEC filing

Congress transactions 1

All Congress filings
Purchase disclosed

NeoGenomics, Inc. - Common Stock (NEO) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
August 7, 2026
Filed September 10, 2026 · 34d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001077183
Latest public acceptance
Oct 5, 2026, 08:29 PM UTC
Score calculated
Oct 8, 2026, 12:05 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.